Isoniazid-induced fever.

J F Dasta; J A Prior; S Kurzrok

doi:10.1378/chest.75.2.196

Home/Archive/PubMed

PubMed · 421557

Isoniazid-induced fever.

J F Dasta·J A Prior·S Kurzrok

View original source ↗Export metadata ↓

Abstract

A 56-year-old man was started on therapy with isoniazid after exhibiting a positive reaction to an intradermal injection of intermediate-strength purified protein derivative of tuberculin. After the first dose and each of the following three doses, nausea, vomiting, chills, and an elevated body temperature ranging from 38 degrees C (100.4 degrees F) to 40 degrees C (104. degrees F) occurred. There was no evidence of a hypersensitivity reaction to isoniazid, such as cutaneous rash, eosinophilia, elevated concentration of IgE, and abnormal results on tests of hepatic function. Following discontinuance of therapy with isoniazid, the temperature returned to normal. This experience illustrates the potential of isoniazid to cause febrile reactions, a situation that could be misdiagnosed as an infectious process.

Explore related subjects

Carcinoma, Squamous Cell Drug Hypersensitivity Fever Humans Isoniazid Lung Neoplasms Male Middle Aged Tuberculosis, Pulmonary Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J F Dasta, J A Prior, S Kurzrok. 1979. Isoniazid-induced fever.. https://doi.org/10.1378/chest.75.2.196

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2017

Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.

We previously reported a novel association between CDKN2A nonpromoter methylation and transcription (ARF/INK4a) in human papillomavirus associated oropharyngeal tumors. In this study we assessed whether nonpromoter CDKN2A methylation in laryngeal squamous cell carcinomas (LXSCC) conferred a similar association with transcription that predicted patient outcome. We compared DNA methylation and ARF/INK4a RNA expression levels for the CDKN2A locus using the Illumina HumanMethylation27 beadchip and RT-PCR in 43 LXSCC tumor samples collected from a prospective study of head and neck cancer patients treated at Montefiore Medical Center (MMC). Validation was performed using RNAseq data on 111 LXSCC tumor samples from the Cancer Genome Atlas (TCGA). The clinical relevance of combined nonpromoter CDKN2A methylation and transcription was assessed by multivariate Cox regression for locoregional recurrence on a subset of 69 LXSCC patients with complete clinicopathologic data from the MMC and TCGA cohorts. We found evidence of CDKN2A nonpromoter hypermethylation in a third of LXSCC from our MMC cohort, which was significantly associated with increased ARF and INK4a RNA expression (Wilcoxon rank-sum, P = 0.007 and 0.003, respectively). A similar association was confirmed in TCGA samples (Wilcoxon rank-sum test P < 0.0001 for ARF and INK4a). Patients with CDKN2A hypermethylation or high ARF/INK4a expression were significantly less likely to develop a locoregional recurrence compared to those with neither of the features, independent of other clinicopatholgic risk factors (adjusted hazard ratio=0.21, 95% confidence interval:0.05-0.81). These results support the conclusion that CDKN2A nonpromoter methylation is associated with increased ARF and INK4a RNA expression, and improved locoregional control in LXSCC.

Carcinoma, Squamous Cell↗

PubMed1979

[A statistical analysis concerning the routes of dissemination of cancer of the esophagus based on the autopsy records (author's transl)].

Explore the source record for details and available documents.

Carcinoma, Squamous Cell↗

PubMed1979

[Evaluation of cytophotometric DNA-measurements of samples from the uterine cervix (author's transl)].

Results of DNA-cytophotometric studies of samples from the uterine cervix are evaluated in normal cervical epithelia, inflammation, dysplasia, carcinoma in situ, and invasive squamous cell carcinoma. As to their significance for cytology-automation the results suggest an arbitrary DNA-value in the range of 4.5 to 5 c by which precancerous lesions and invasive squamous cell carcinoma can be distinguished from benign squamous epithelia. Possibly a higher DNA-value is acceptable if larger cell populations are analyzed.

Carcinoma, Squamous Cell↗